Khan, Amir http://orcid.org/0000-0001-6135-5399
Roy, Payel http://orcid.org/0000-0003-2511-068X
Ley, Klaus http://orcid.org/0000-0001-9339-3672
Article History
Accepted: 12 February 2024
First Online: 12 March 2024
Competing interests
: K.L. is a co-founder of Atherovax, a biotech company developing a tolerogenic vaccine for atherosclerosis. The other authors declare no competing interests.